Shop ATS / CDC / ERS / IDSA Treatment of Drug-Resistant Tuberculosis

Treatment of Drug-Resistant Tuberculosis

American Thoracic SocietyCenters for Disease Control and PreventionEuropean Respiratory SocietyInfectious Diseases Society of America
Published: November 2019
Print Copy Information:
  • 16 pages
  • Spiral Bound
  • 80# Aqueous Coating
  • 4.25" x 7.25"
  • Ships in 5 – 10 business days
What's Inside
Bulk and Institutional Ordering
About the Authors
Additional Information
  • Key Points
  • Summary of Good Practices
  • Treatment Recommendations
    • For the selection of an effective MDR-TB treatment regimen and duration of MDR-TB treatment
    • For the selection of oral drugs for MDR-TB treatment
    • For selected oral drugs previously included in regimens for the treatment of MDR-TB
    • For the selection of drugs administered through injection when needed to compose an effective treatment regimen for MDR-TB
    • For the use of the WHO-recommended standardized shorter-course 9–12 month regimen for MDR-TB
    • For the role of surgery in the treatment of MDR-TB
    • For the treatment of isoniazid-resistant TB
    • For the management of contacts to patients with MDR-TB
  • Tables
    • Summary of Recommendations on Drugs for Use in a Treatment Regimen for Patients with MDR-TB, Including Strength of Recommendation, Certainty in the Evidence and Relative Effects on Death and Treatment Success
    • Clinical Strategy to Build an Individualized Treatment Regimen for MDR-TB
    • Doses of Drugs for Treatment of Adults and Children with MDR-TB
    • Select Antiretroviral and Non–rifamycin-based Anti-tuberculosis Drug Overlapping Toxicities and Potential Adverse Drug-drug Interactions
  • For purchases under 100 in quantity, we suggest placing the order directly through the website.
  • We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
  • We are proud to offer special discounts to medical schools, training programs, students and more.
  • We offer bulk purchase discounts based on number of copies and number of titles.

Contact Us for more details

The roots of the American Thoracic Society reach back to 1905, when a small group of physicians decided that the best way to improve care for tuberculosis patients was to share their experiences and discoveries. Today, the ATS has grown into an international society with more than 15,000 members. In this introductory section, you will find information about the people and programs that make the ATS the world's leading medical association dedicated to advancing our clinical and scientific understanding of pulmonary diseases, critical illnesses and sleep-related breathing disorders.

The European Respiratory Society, or ERS, is a non-profit organization with offices in Lausanne, Brussels and Sheffield.

The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.


This resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers after consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary.

You can also find this product included in these bundles!

Need help?